Jewish Men in Middle of PSA Controversy

Are the Risks of Prostate Screening Worth the Rewards?

Doubly at Risk: Rabbi Jon Adland, with wife Sandy in Pittsburgh, has two BRCA mutations.
Courtesy jon adland
Doubly at Risk: Rabbi Jon Adland, with wife Sandy in Pittsburgh, has two BRCA mutations.

By Talia Bloch

Published August 13, 2012, issue of August 17, 2012.
  • Print
  • Share Share
  • Single Page

A year ago, Rabbi Jon Adland underwent genetic testing and discovered that he was positive for mutations on both BRCA1 and BRCA2 — the so-called breast cancer genes that raise the risk for breast and ovarian cancer, especially in Ashkenazi Jews, who are over 10 times more likely to have a BRCA mutation than those in the general population.

“I went in thinking, Oh, I’m going to be fine, but I came out with both. Not every man gets to hit a home run,” said Adland, 58, who is the rabbi of Temple Israel in Canton, Ohio.

Adland decided to get tested after several family members were diagnosed with breast and ovarian cancers. What he did not realize was that BRCA also has been linked to prostate cancer risks. “I learned about it when I went in for genetic counseling. It was a bit of a surprise to me,” he said. The counselor and his physician therefore advised Adland to regularly get a PSA test, a blood test that measures a protein in the blood produced by cells where most prostate cancers begin.

Ever since the PSA, or prostate-specific antigen, test was first used in the mid-1980s, it has become the gold standard of prostate cancer screening, with most guidelines suggesting that men be screened once a year, starting at age 50 or somewhat earlier, if they are at elevated risk for the disease. But recent controversy surrounding the PSA test has left many wondering what men like Adland should be doing to monitor their prostates.

Last May, the government-backed U.S. Preventive Services Task Force released guidelines recommending that physicians stop using the PSA test to screen for prostate cancer. The Task Force, an advisory board of independent medical experts, came to this conclusion based on a review of two major screening trials of men — one in Europe and one in the United States.

After skin cancer, prostate cancer is the second most common cancer among men in the U.S. and the second leading cause of cancer deaths worldwide, after lung cancer. Yet, when caught early, prostate cancer usually has a good prognosis.

As a screening tool, however, the PSA test has some significant flaws. Prostate cancer often grows at such a slow rate that, depending on his age and health, a man diagnosed with the disease may have a good chance of dying from other causes before the cancer can cause any harm. Further complicating the picture is the fact that as men age their prostates often become enlarged and produce more PSA, even if the growth is benign. False positives have increased in recent years, as the cut-off level for a supposedly worrisome PSA number has dropped.

Finally, further diagnosis and treatment can have considerable side effects. As many as one third of men who had biopsies for abnormal test results, according to the Task Force, experienced pain, fever, bleeding, infection or transient urinary difficulties. Treatment for the cancer itself is even more fraught with complications, including erectile dysfunction, impotence, urinary incontinence and, in rare instances, heart attack or stroke.

As a consequence, controversy has swirled around the PSA test for some time now, with critics talking of over-diagnosis and over-treatment. “It was the assessment of the Task Force that the potential benefits from prostate cancer screening do not outweigh the harms,” said Dr. Michael LeFevre, director of clinical services at the University of Missouri’s School of Medicine and co-vice chair of the Task Force. “The treatments cause harm in greater numbers of men who have a disease that would never have hurt them in their lifetime.”

The Task Force’s guidelines ignited debate and criticism. While many in the medical community agree with its critique of how the PSA test has come to be used, others believe their recommendations went too far.


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • Happy birthday to the Boy Who Lived! July 31 marks the day that Harry Potter — and his creator, J.K. Rowling — first entered the world. Harry is a loyal Gryffindorian, a matchless wizard, a native Parseltongue speaker, and…a Jew?
  • "Orwell would side with Israel for building a flourishing democracy, rather than Hamas, which imposed a floundering dictatorship. He would applaud the IDF, which warns civilians before bombing them in a justified war, not Hamas terrorists who cower behind their own civilians, target neighboring civilians, and planned to swarm civilian settlements on the Jewish New Year." Read Gil Troy's response to Daniel May's opinion piece:
  • "My dear Penelope, when you accuse Israel of committing 'genocide,' do you actually know what you are talking about?"
  • What's for #Shabbat dinner? Try Molly Yeh's coconut quinoa with dates and nuts. Recipe here:
  • Can animals suffer from PTSD?
  • Is anti-Zionism the new anti-Semitism?
  • "I thought I was the only Jew on a Harley Davidson, but I was wrong." — Gil Paul, member of the Hillel's Angels. http://jd.fo/g4cjH
  • “This is a dangerous region, even for people who don’t live there and say, merely express the mildest of concern about the humanitarian tragedy of civilians who have nothing to do with the warring factions, only to catch a rash of *** (bleeped) from everyone who went to your bar mitzvah! Statute of limitations! Look, a $50 savings bond does not buy you a lifetime of criticism.”
  • That sound you hear? That's your childhood going up in smoke.
  • "My husband has been offered a terrific new job in a decent-sized Midwestern city. This is mostly great, except for the fact that we will have to leave our beloved NYC, where one can feel Jewish without trying very hard. He is half-Jewish and was raised with a fair amount of Judaism and respect for our tradition though ultimately he doesn’t feel Jewish in that Larry David sort of way like I do. So, he thinks I am nuts for hesitating to move to this new essentially Jew-less city. Oh, did I mention I am pregnant? Seesaw, this concern of mine is real, right? There is something to being surrounded by Jews, no? What should we do?"
  • "Orwell described the cliches of politics as 'packets of aspirin ready at the elbow.' Israel's 'right to defense' is a harder narcotic."
  • From Gene Simmons to Pink — Meet the Jews who rock:
  • The images, which have since been deleted, were captioned: “Israel is the last frontier of the free world."
  • As J Street backs Israel's operation in Gaza, does it risk losing grassroots support?
  • What Thomas Aquinas might say about #Hamas' tunnels:
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.